Read more about Brazil halting coronavirus vaccine CoronaVac trial surprises the world on Business Standard. The potential vaccine is being developed by Chinese biopharmaceutical firm Sinovac and in Brazil would be mostly produced by Sao Paulo’s state-run Butantan Institute
Brazil’s health regulator has halted clinical trials of the potential CoronaVac, citing an “adverse, serious event.” The decision posted on Anvisa’s website Monday night elicited immediate surprise from parties involved in producing the vaccine. The potential vaccine is being developed by Chinese biopharmaceutical firm Sinovac and in would be mostly produced by Sao Paulo’s state-run Butantan Institute. Sao Paulo state’s government said in a statement it “regrets being informed by the press and not directly by Anvisa, as normally occurs in clinical trials of this nature.
